MBX Biosciences, Working Capital vs. Market Capitalization
| MBX Stock | 19.83 1.14 5.44% |
For MBX Biosciences, profitability analysis, we use financial ratios and fundamental drivers that measure the ability of MBX Biosciences, to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well MBX Biosciences, Common utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between MBX Biosciences,'s most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of MBX Biosciences, Common over time as well as its relative position and ranking within its peers.
MBX |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MBX Biosciences,. If investors know MBX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MBX Biosciences, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.48) |
The market value of MBX Biosciences, Common is measured differently than its book value, which is the value of MBX that is recorded on the company's balance sheet. Investors also form their own opinion of MBX Biosciences,'s value that differs from its market value or its book value, called intrinsic value, which is MBX Biosciences,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MBX Biosciences,'s market value can be influenced by many factors that don't directly affect MBX Biosciences,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MBX Biosciences,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if MBX Biosciences, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MBX Biosciences,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
MBX Biosciences, Common Market Capitalization vs. Working Capital Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining MBX Biosciences,'s current stock value. Our valuation model uses many indicators to compare MBX Biosciences, value to that of its competitors to determine the firm's financial worth. MBX Biosciences, Common is regarded fourth in working capital category among its peers. It is considered to be number one stock in market capitalization category among its peers creating about 8.50 of Market Capitalization per Working Capital. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MBX Biosciences,'s earnings, one of the primary drivers of an investment's value.MBX Market Capitalization vs. Working Capital
Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
MBX Biosciences, |
| = | 79.54 M |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
MBX Biosciences, |
| = | 676.25 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
MBX Market Capitalization vs Competition
MBX Biosciences, Common is considered to be number one stock in market capitalization category among its peers. Market capitalization of Health Care industry is now estimated at about 1.64 Billion. MBX Biosciences, totals roughly 676.25 Million in market capitalization claiming about 41% of equities under Health Care industry.
MBX Biosciences, Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in MBX Biosciences,, profitability is also one of the essential criteria for including it into their portfolios because, without profit, MBX Biosciences, will eventually generate negative long term returns. The profitability progress is the general direction of MBX Biosciences,'s change in net profit over the period of time. It can combine multiple indicators of MBX Biosciences,, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 2.7 M | 1.5 M | |
| Interest Income | 2.7 M | 1.7 M | |
| Operating Income | -35.3 M | -37.1 M | |
| Net Loss | -32.6 M | -34.2 M | |
| Income Before Tax | -32.6 M | -34.2 M | |
| Total Other Income Expense Net | -874.8 K | -918.5 K | |
| Net Loss | -32.6 M | -34.2 M |
MBX Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on MBX Biosciences,. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of MBX Biosciences, position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the MBX Biosciences,'s important profitability drivers and their relationship over time.
Use MBX Biosciences, in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MBX Biosciences, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MBX Biosciences, will appreciate offsetting losses from the drop in the long position's value.MBX Biosciences, Pair Trading
MBX Biosciences, Common Pair Trading Analysis
The ability to find closely correlated positions to MBX Biosciences, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MBX Biosciences, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MBX Biosciences, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MBX Biosciences, Common to buy it.
The correlation of MBX Biosciences, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MBX Biosciences, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MBX Biosciences, Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MBX Biosciences, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your MBX Biosciences, position
In addition to having MBX Biosciences, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Chemicals Thematic Idea Now
Chemicals
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Chemicals theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Chemicals Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for MBX Stock Analysis
When running MBX Biosciences,'s price analysis, check to measure MBX Biosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MBX Biosciences, is operating at the current time. Most of MBX Biosciences,'s value examination focuses on studying past and present price action to predict the probability of MBX Biosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MBX Biosciences,'s price. Additionally, you may evaluate how the addition of MBX Biosciences, to your portfolios can decrease your overall portfolio volatility.